Elisabeth Schorb
University of Freiburg(DE)University Medical Center Freiburg(DE)
Publications by Year
Research Areas
CNS Lymphoma Diagnosis and Treatment, Lymphoma Diagnosis and Treatment, Glioma Diagnosis and Treatment, Brain Metastases and Treatment, CAR-T cell therapy research
Most-Cited Works
- → Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial(2016)590 cited
- → Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial(2017)369 cited
- → High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)(2016)181 cited
- → High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial(2016)169 cited
- → Long-term cognitive function, neuroimaging, and quality of life in primary CNS lymphoma(2013)154 cited
- → Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial(2022)153 cited
- → Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas(2022)118 cited
- → Transfusion-transmitted hepatitis E in Germany, 2013(2014)106 cited
- → Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma—a long-term follow-up study(2012)104 cited
- → Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation(2013)95 cited